1Department of Surgery, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam.
2Department of Surgery, Erasmus Medical Center, Rotterdam.
J Natl Compr Canc Netw. 2020 Jun;18(6):704-711. doi: 10.6004/jnccn.2020.7528.
This study sought to assess patient satisfaction and quality of life (QoL) before and after treatment of pancreatic and periampullary cancer.
We conducted a prospective multicenter study of patients treated for pancreatic and periampullary cancer. General patient satisfaction was measured using the EORTC satisfaction with care questionnaire (IN-PATSAT32) at baseline and 3 months after treatment initiation, with a 10-point change on the Likert scale considered clinically meaningful. QoL was measured using the EORTC Core Quality of Life Questionnaire (QLQ-C30). The influence of treatment (curative and palliative) on patient satisfaction and QoL was determined.
Of 100 patients, 71 completed follow-up questionnaires. General satisfaction with care decreased from 74.3 before treatment to 61.9 after treatment (P<.001), whereas global QoL increased from 68.4 to 71.4 (P=.39). Clinically meaningful reductions were also observed for the reported interpersonal skills of doctors (from 73.4 to 63.3) and exchange of information within the care team (from 63.5 to 52.5). Satisfaction scores were lower for patients treated with curative intent than for those treated with palliative intent regarding interpersonal skills of doctors (P=.01), information provision by doctors (P=.004), information provision by nurses (P=.02), availability of nurses (P=.004), exchange of information within the care team (P=.01), and hospital access (P=.02). In multivariable analysis, clinicopathologic or QoL factors were not independently associated with general patient satisfaction.
Satisfaction with care, but not QoL, decreased after pancreatic cancer treatment. Improvements in communication and interpersonal skills are needed to maintain patient satisfaction after treatment.
本研究旨在评估胰腺和胰周癌症患者治疗前后的满意度和生活质量（QoL）。
我们进行了一项针对胰腺和胰周癌症患者的前瞻性多中心研究。在治疗开始前和 3 个月时，使用 EORTC 护理满意度问卷（IN-PATSAT32）测量一般患者满意度，Likert 量表上 10 分的变化被认为具有临床意义。使用 EORTC 核心生活质量问卷（QLQ-C30）测量 QoL。确定治疗（治愈性和姑息性）对患者满意度和 QoL 的影响。
在 100 名患者中，71 名完成了随访问卷。治疗前患者对护理的总体满意度为 74.3%，治疗后降至 61.9%（P<.001），而全球 QoL 从 68.4 增加到 71.4（P=.39）。医生人际技能（从 73.4 降至 63.3）和护理团队内信息交流（从 63.5 降至 52.5）的报告也观察到了有临床意义的降低。与姑息性治疗的患者相比，以治愈为目的治疗的患者对医生的人际技能（P=.01）、医生提供的信息（P=.004）、护士提供的信息（P=.02）、护士的可用性（P=.004）、护理团队内的信息交流（P=.01）和医院就诊（P=.02）的满意度评分较低。多变量分析显示，临床病理或 QoL 因素与一般患者满意度无独立相关性。
胰腺癌症治疗后护理满意度下降，但生活质量未下降。需要改善沟通和人际技能，以维持治疗后的患者满意度。
